Rocket Lab's Market Mismatch: Record Backlog, Regulatory Headwinds, and the Hungry Hippo Problem

Rocket Lab's stock fell 11% last week after SpaceX sought FCC review of its Iridium deal, despite strong Q2 results and a $2.36B backlog.

There is a peculiar disconnect at the heart of Rocket Lab's current story. The company is posting operational milestones at a pace that would make most aerospace firms envious, yet its stock just suffered its worst week in recent memory. The gap between what the business is doing and what the market is pricing has rarely been wider.

The numbers tell the tale from both sides. On Friday, shares closed at EUR 55.60, down 4.1 percent on the day and 11 percent for the week. That puts the stock roughly 58 percent below its 52-week high of EUR 133.80, though still 71 percent above its yearly low of EUR 32.60. The volatility, however, has little to do with Rocket Lab's own execution — the trigger was a competitor's regulatory filing.

SpaceX Throws a Wrench Into the Iridium Deal

The immediate catalyst for the sell-off was news that SpaceX has asked the US Federal Communications Commission to review Rocket Lab's planned USD 8 billion Iridium transaction. The rival launch provider is citing a spectrum conflict with its own Starlink gateways, and the resulting uncertainty rippled across the entire space sector, not just Rocket Lab's shares.

That regulatory overhang matters because the Iridium deal is central to Rocket Lab's ambitions in satellite services. The company has been building out vertically integrated capabilities, most recently through the acquisition of Iridium business units and optical support capacity. How quickly the FCC resolves the matter could determine whether Rocket Lab can execute its growth strategy in the satellite segment without delay.

A Business That Keeps Delivering

While the stock stumbles, the operational picture is arguably the strongest it has ever been. August brought the 93rd Electron mission — the 14th launch of 2026 — which delivered the ninth iQPS Earth-observation satellite to orbit with a claimed 100 percent success rate. Days earlier, eight satellite platforms for MDA Space reached orbit, the first batch of a 17-platform constellation tied to a USD 143 million Globalstar direct-communication contract.

The defense pipeline is equally active. Rocket Lab joined the Space Data Network Consortium of the US Space Force and secured two delivery orders totaling USD 12 million for secure optical communications under the SDN-B program. That marked the second military-related announcement in a fortnight, underscoring how deeply the company has embedded itself in defense satellite infrastructure.

The company also recently launched a satellite for the US Space Force's Victus Haze exercise in 16 hours and 42 minutes — well under the 24-hour requirement — and NASA selected Rocket Lab for two science missions, PolSIR and TSIS-2, backed by a VADR contract worth up to USD 300 million over ten years.

Second-quarter 2026 results reinforce the growth narrative: revenue of USD 234.07 million beat consensus estimates of USD 231.62 million, while the backlog reached USD 2.36 billion, up 137 percent year over year. Launch backlog now exceeds 90 missions across Electron, HASTE, and Neutron. The caveat: a GAAP net loss of USD 49.3 million, and earnings per share of minus USD 0.08, slightly worse than the minus USD 0.06 analysts had penciled in.

Neutron: The Nail-Biter

For all the attention on Iridium and military contracts, the real swing factor for investors remains a single piece of hardware: Neutron's reusable fairing, internally nicknamed "Hungry Hippo." Testing under flight-like conditions continues, but the window for delivering the rocket to the launch pad in the fourth quarter of 2026 is narrowing.

CFO Adam Spice has hinted that a successful Neutron test flight could push the company into positive adjusted operating territory as soon as the following quarter. That single sentence captures how much hope rests on this unproven vehicle. Electron has established itself as a reliable workhorse, but Neutron is still a promise — one that would put Rocket Lab in direct competition with SpaceX for heavier payloads, with a capacity exceeding 28,000 pounds to low Earth orbit.

A New Customer Chooses Rocket Lab Over SpaceX

That competitive dynamic just got more interesting. Kepler Communications, a Canadian satellite operator, has booked the first full Neutron flight — a notable vote of confidence given that the rocket has yet to complete a single test launch, with the debut mission not expected before 2028 at the earliest. Kepler's decision to pick Rocket Lab over SpaceX suggests the company's pitch of vertically integrated solutions is resonating with customers willing to bet on future capability.

Insider Sales Follow the Familiar Playbook

Adding to the noise, several executives sold shares on August 24. Chief Accounting Officer Agostino Ricupati, SVP Arjun Kampani, and another insider named Frank Klein disposed of stock at USD 69.63 per share. The sales were conducted under Rule 10b5-1 plans, which are pre-scheduled and typically designed to cover tax liabilities from equity compensation. Such automated programs are standard practice across US technology firms and are not generally read as a signal of management pessimism — they follow a fixed timetable regardless of where the stock trades.

Analyst Consensus Remains Constructive

Despite the recent weakness, Wall Street remains largely positive. Of 22 brokerages covering the stock, 13 rate it a Buy and three a Strong Buy, alongside five Holds and one Sell. The average price target stands at USD 110.65, well above current levels, and the consensus rating is "Moderate Buy."

The twelve-month picture supports that optimism: shares are still up 35 percent over that horizon. The market is clearly rewarding the fundamental growth story even as near-term headlines — insider sales, regulatory friction, and Neutron's uncertain timeline — keep injecting volatility.

The central question for observers is not whether Rocket Lab is growing; the evidence says it is. The real test is whether the company can deliver on its technical promises before market patience runs out. With a record backlog, a deepening defense footprint, and a heavy-lift rocket still unproven, Rocket Lab is running a race between its own execution and the market's expectations.